Causality & Seriousness Assessment · Section 6.3
~6 min read · The Drug Safety Coach — Global PV Career Course
Key points
The three states, defined
| Term | Definition | Positive result means |
|---|---|---|
| Challenge | Giving the drug to the patient — the initial exposure being assessed. | N/A — challenge is the starting exposure, not an outcome |
| Dechallenge | Stopping the drug, usually after the adverse event, or at the end of planned treatment. Can be complete or partial. | Positive dechallenge: the event improves or disappears after the drug is stopped |
| Rechallenge | Restarting the same drug after having stopped it, usually specifically to test the reaction. Can be complete or partial. | Positive rechallenge: the event recurs after the drug is restarted |
Full text
Challenge, dechallenge, and rechallenge are the vocabulary the WHO-UMC scale’s dechallenge and rechallenge criteria actually run on, and they’re worth understanding precisely rather than approximately, because "positive" and "negative" mean the opposite of what intuition might suggest. Challenge is simply the drug being given to the patient — the exposure under assessment, not an outcome in itself.
Dechallenge is stopping the drug, and it can happen for reasons that have nothing to do with the adverse event — the end of a planned treatment course, for instance — or specifically because of it. A positive dechallenge means the adverse event improves or disappears after the drug is stopped, which supports a causal role for the drug but doesn’t prove it, since plenty of adverse events resolve on their own regardless of whether the drug is still being given. A negative dechallenge means the event persists despite stopping the drug — which, depending on the type of event, can either argue against the drug being the cause, or simply reflect that some drug-induced injuries don’t reverse quickly even after the drug is withdrawn.
Rechallenge is restarting the same drug after it was stopped, and it’s the single strongest piece of evidence the WHO-UMC framework can draw on — a positive rechallenge, where the event recurs after the drug is restarted, is very difficult to explain by anything other than the drug itself, which is exactly why it’s required for the "Certain" category. The catch is that rechallenge is rarely performed deliberately, for the obvious reason that it means intentionally re-exposing a patient to something suspected of having harmed them. When rechallenge does happen, it’s usually because a clinician didn’t initially connect the first event to the drug, restarted it for unrelated reasons, and only recognised the pattern when the reaction recurred.
This is why dechallenge and rechallenge information, when present in a case, deserves careful attention in both the causality assessment and the narrative — a positive rechallenge documented in a case is genuinely rare, genuinely strong evidence, and worth making unmistakably clear rather than burying in a subordinate clause. Module 5’s narrative-writing lessons touched on this directly: outcome and dechallenge/rechallenge information is its own section in a compliant narrative precisely because of how much causality weight it can carry.
Quick check
Test yourself before moving on — no pressure, just click an answer.
1. What does a "positive" dechallenge mean?
2. Why is rechallenge, when documented, considered such strong causality evidence?